Idarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia
Leuk Lymphoma
.
2024 Nov;65(11):1737-1739.
doi: 10.1080/10428194.2024.2373324.
Epub 2024 Jul 7.
Authors
Kendall Diebold
1
,
Garrett Bourne
2
,
Manuel Espinoza-Gutarra
1
,
Zaid Al-Kadhimi
1
,
Kimo Bachiashvili
1
,
Sravanti Rangaraju
1
,
Pankit Vachhani
1
,
Ravi Bhatia
1
,
Omer Jamy
1
Affiliations
1
Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
2
Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
PMID:
38972060
DOI:
10.1080/10428194.2024.2373324
No abstract available